Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MTATP6P21 is a mitochondrial pseudogene resembling MT-ATP6. Pseudogenes are genomic DNA sequences related to genes but without coding capacity, usually lacking known biological, disease, or therapeutic relevance. The functional gene, MT-ATP6, encodes ATP synthase membrane subunit 6, a crucial protein for cellular energy production through oxidative phosphorylation; however, MTATP6P21 is inactive and does not produce protein, is not linked to human disease, nor is it considered a drug target[1][7][3][8]. If the intended target is druggable or biologically relevant, information should be sought for MT-ATP6 (mitochondrially encoded ATP synthase membrane subunit 6), not MTATP6P21.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrially encoded ATP synthase 6 pseudogene 21 (MTATP6P21).